We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
febit Launches new Instrument for Targeted NextGen Sequencing with High Sample Throughput
Product News

febit Launches new Instrument for Targeted NextGen Sequencing with High Sample Throughput

febit Launches new Instrument for Targeted NextGen Sequencing with High Sample Throughput
Product News

febit Launches new Instrument for Targeted NextGen Sequencing with High Sample Throughput


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "febit Launches new Instrument for Targeted NextGen Sequencing with High Sample Throughput"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

febit has announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.

AGBT is now widely regarded as the premier scientific forum for sharing information about the latest advances in new DNA sequencing technologies and their application to diverse areas in biology and biomedical research. The new HybSelector instrument will replace the Geniom RT Analyzer for high-quality DNA enrichment followed by targeted next-generation sequencing.

The compact HybSelector combines febit’s well established expertise in the development and manufacture of technologies for genome exploration with the most advanced high-quality DNA enrichment automation available on the market.

“The HybSelector features all technical components necessary for HybSelect, our DNA enrichment protocol,” said Peer Staehler, CSO at febit. “We are able to offer the HybSelector at a very competitive price. This will enable the large genomics research community, which has already indicated a high interest in affordable targeted re-sequencing solutions, to use HybSelect’s high sample throughput at low acquisition costs.”

The economic benefit of HybSelect increases the potential for widespread use of next generation sequencing in clinical studies. Instead of sequencing the complete genomes of only a limited number of patients, HybSelect enables the analysis of specific genes of interest from large patient cohorts for the same price and data management effort. The larger patient pool now provides the statistically relevant data that are necessary for clinical studies.
Advertisement